Publication | Open Access

Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment

UrologySurgical OncologyGenitourinary CancerTumor HeterogeneityMedicinePerioperative Anti-fgfr3 TreatmentPathologyFibroblast Growth FactorCancer GeneticsOncologyInvasive Bladder CancerTumor BiologyCancer Growth